Related references
Note: Only part of the references are listed.T cell and antibody responses to SARS-CoV-2: Experience from a French transplantation and hemodialysis center during the COVID-19 pandemic
Sophie Candon et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
Impact of COVID-19 in solid organ transplant recipients
Lara Danziger-Isakov et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
Is COVID-19 infection more severe in kidney transplant recipients?
Sophie Caillard et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients
Brian J. Boyarsky et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients
Ilies Benotmane et al.
KIDNEY INTERNATIONAL (2021)
COVID-19 and Solid Organ Transplantation: A Review Article
Yorg Azzi et al.
TRANSPLANTATION (2021)
Practical Guide to Vaccination in All Stages of CKD, Including Patients Treated by Dialysis or Kidney Transplantation
Karen M. Krueger et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2020)
Opportunistic infections after conversion to belatacept in kidney transplantation
Dominique Bertrand et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe
Kitty J. Jager et al.
KIDNEY INTERNATIONAL (2020)
An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants
Sophie Caillard et al.
KIDNEY INTERNATIONAL (2020)
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Edward E. Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)
Olivier Thaunat et al.
KIDNEY INTERNATIONAL (2020)
Opportunistic Infections and Efficacy Following Conversion to Belatacept-Based Therapy after Kidney Transplantation: A French Multicenter Cohort
Dominique Bertrand et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Influenza vaccine strategies for solid organ transplant recipients
Cedric Hirzel et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2018)
Protective Cytomegalovirus (CMV)-Specific T-Cell Immunity Is Frequent in Kidney Transplant Patients without Serum Anti-CMV Antibodies
Nicolle H. R. Litjens et al.
FRONTIERS IN IMMUNOLOGY (2017)
Changes of immunogenic profiles between a single dose and one booster influenza vaccination in hemodialysis patients - an 18-week, open-label trial
Yu-Tzu Chang et al.
SCIENTIFIC REPORTS (2016)
Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe
P. Perez-Romero et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Preformed Frequencies of Cytomegalovirus (CMV)-Specific Memory T and B Cells Identify Protected CMV-Sensitized Individuals Among Seronegative Kidney Transplant Recipients
Marc Lucia et al.
CLINICAL INFECTIOUS DISEASES (2014)
Vaccination in Solid Organ Transplantation
L. Danziger-Isakov et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Serologic Vaccination Response after Solid Organ Transplantation: A Systematic Review
Isabella Eckerle et al.
PLOS ONE (2013)
Safety and immunogenicity of a 2009 influenza A (H1N1) vaccine in hemodialysis patients
Paungpaga Lertdumrongluk et al.
VACCINE (2012)
Efficacy of Influenza A H1N1/2009 Vaccine in Hemodialysis and Kidney Transplant Patients
Marta Crespo et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Maintenance immunosuppressive therapy with everolimus preserves humoral immune responses
Geertrude H. Struijk et al.
KIDNEY INTERNATIONAL (2010)
Share Paper
